Brief CBT for Anxiety and Advanced Cancer

Completed · Phase 2

Conditions studied: Anxiety, Depression, Unspecified Adult Solid Tumor, Protocol Specific, Cancer, Cognitive Behavioral Therapy

In brief

RATIONALE: Providing cognitive-behavioral therapy (CBT) may reduce anxiety and improve quality of life of patients with advanced cancer. PURPOSE: To examine the development and pilot testing of a brief cognitive-behavioral therapy intervention to treat anxiety and improve quality of life in patients with advanced cancer. Hypothesis: Patients with anxiety associated with advanced cancer who receive CBT will report significantly fewer anxiety symptoms compared to those in the comparison condition.

Key facts

Study ID

NCT00706290

Run by

Massachusetts General Hospital

People needed

49

Starts

2007-04-01

Expected to finish

2010-08-01

Last updated by the study team

2014-06-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of incurable solid tumor cancers
• At least four weeks post-diagnosis
• Current symptoms of anxiety and anxiety as principal psychiatric problem
• Patients with co-morbid depression are eligible as long as anxiety symptoms are primary
• Concurrent pharmacotherapy for anxiety allowed

You may not qualify if…

• Delirium or dementia
• Active and untreated major psychiatric condition such as schizophrenia or bipolar disorder, other psychotic disorders, or substance dependence
• Other inability to complete informed consent process or study procedures

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.